Lista de obras - Daniel A. Alcolea - Dominio Público Uruguay

(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia

artículo científico publicado en 2010

A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk

artículo científico publicado en 2017

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

scientific article published on 18 December 2019

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica

APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls

artículo científico publicado en 2015

APP-derived peptides reflect neurodegeneration in frontotemporal dementia

artículo científico publicado en 2019

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse

scientific article published on 28 August 2019

Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease

artículo científico publicado en 2015

Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain

artículo científico publicado en 2015

Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer's disease

artículo científico publicado en 2020

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

artículo científico publicado en 2017

BIOMARKERS IN CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATION

Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease

artículo científico publicado en 2020

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease

scientific article published on 01 January 2020

CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study

artículo científico publicado en 2016

CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum

scientific article published on 05 October 2018

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.

artículo científico

CSF β-AMYLOID AND PHOSHO-TAU INTERACTIONS ON BRAIN STRUCTURE IN PRECLINICAL AD

Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.

artículo científico publicado en 2017

Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami

artículo científico publicado en 2015

Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease

artículo científico publicado en 2017

Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation

artículo científico publicado en 2015

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum.

artículo científico publicado en 2016

Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease

artículo científico publicado en 2014

Challenges associated with biomarker-based classification systems for Alzheimer's disease

scientific article published on 21 April 2018

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid

artículo científico publicado en 2019

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia

artículo científico publicado en 2013

Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation

artículo científico publicado en 2018

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

artículo científico publicado en 2021

Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia.

artículo científico publicado en 2013

Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases

artículo científico publicado en 2015

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

scientific article published on 18 January 2020

Cortical microstructural changes along the Alzheimer's disease continuum

artículo científico publicado en 2017

Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum

scientific article published on 10 September 2020

DOWN ALZHEIMER BARCELONA NEUROIMAGING INITIATIVE (DABNI): A PROSPECTIVE LONGITUDINAL BIOMARKER COHORT TO STUDY ALZHEIMER’S DISEASE IN DOWN SYNDROME

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer's Disease

artículo científico publicado en 2018

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

artículo científico publicado en 2011

Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease

artículo científico publicado en 2021

Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?

artículo científico publicado en 2019

Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.

artículo científico publicado en 2017

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

artículo científico publicado en 2020

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

artículo científico publicado en 2019

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease

artículo científico publicado en 2012

Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion

artículo científico publicado en 2014

Effect of REST on brain metabolism in the Alzheimer disease continuum

artículo científico publicado en 2015

Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD

article

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia.

artículo científico publicado en 2012

Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.

artículo científico publicado en 2016

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain

artículo científico publicado en 2014

Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2012

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

artículo científico publicado en 2021

Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform

scientific article published on 20 December 2018

Inflammation markers in CSF and MRI spectroscopy in Alzheimer's disease pre-dementia stages

scholarly article by Daniel A. Alcolea et al published July 2013 in Alzheimer's and Dementia

Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid

artículo científico publicado en 2016

Longitudinal brain structural changes in preclinical Alzheimer's disease

artículo científico publicado en 2016

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease

artículo científico publicado en 2013

Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis

scientific article published on 15 July 2020

OBESITY IS ASSOCIATED WITH INCREASED CSF PHOSPHO-TAU LEVELS AND COGNITIVE DECLINE IN HEALTHY ELDERLY

Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study

artículo científico publicado en 2018

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

artículo científico publicado en 2015

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

scientific article published on 29 August 2018

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

artículo científico publicado en 2021

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations

artículo científico publicado en 2016

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

artículo científico publicado en 2013

Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-β peptide aggregation

artículo científico publicado en 2014

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

artículo científico publicado en 2015

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

artículo científico publicado en 2018

Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.

artículo científico publicado en 2015

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers

article

RELATIONSHIP BETWEEN CSF YKL-40 AND CORTICAL THICKNESS

Rapidly progressive dementia: experience in a tertiary care medical center

artículo científico

Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

artículo científico publicado en 2016

Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease

artículo científico publicado en 2015

Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease

artículo científico publicado en 2014

Remote cerebral hematomas in patients treated with intravenous rt-PA.

artículo científico publicado en 2010

Reply: To PMID 23794434.

artículo científico publicado en 2014

Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients

artículo científico publicado en 2020

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

artículo científico publicado en 2014

The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study

artículo científico publicado en 2013

The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone

artículo científico publicado en 2022

The Effect of MAPT H1 and APOE ε4 on Transition from Mild Cognitive Impairment to Dementia

artículo científico publicado en 2010

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

scientific article published on 01 August 2019

The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

artículo científico publicado en 2017

The pitfalls of biomarker-based classification schemes

artículo científico publicado en 2017

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

artículo científico publicado en 2015

Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease

artículo científico publicado en 2017

[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders].

artículo científico publicado en 2013

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

artículo científico publicado en 2016

Lista de obras de Daniel A. Alcolea

(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia

A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls

APP-derived peptides reflect neurodegeneration in frontotemporal dementia

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse

Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease

Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain

Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer's disease

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

BIOMARKERS IN CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATION

Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease

CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study

CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.

CSF β-AMYLOID AND PHOSHO-TAU INTERACTIONS ON BRAIN STRUCTURE IN PRECLINICAL AD

Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.

Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami

Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease

Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum.

Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease

Challenges associated with biomarker-based classification systems for Alzheimer's disease

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia

Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia.

Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Cortical microstructural changes along the Alzheimer's disease continuum

Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum

DOWN ALZHEIMER BARCELONA NEUROIMAGING INITIATIVE (DABNI): A PROSPECTIVE LONGITUDINAL BIOMARKER COHORT TO STUDY ALZHEIMER’S DISEASE IN DOWN SYNDROME

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer's Disease

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease

Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?

Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease

Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion

Effect of REST on brain metabolism in the Alzheimer disease continuum

Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia.

Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain

Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform

Inflammation markers in CSF and MRI spectroscopy in Alzheimer's disease pre-dementia stages

Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid

Longitudinal brain structural changes in preclinical Alzheimer's disease

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease

Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis

OBESITY IS ASSOCIATED WITH INCREASED CSF PHOSPHO-TAU LEVELS AND COGNITIVE DECLINE IN HEALTHY ELDERLY

Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-β peptide aggregation

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers

RELATIONSHIP BETWEEN CSF YKL-40 AND CORTICAL THICKNESS

Rapidly progressive dementia: experience in a tertiary care medical center

Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease

Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease

Remote cerebral hematomas in patients treated with intravenous rt-PA.

Reply: To PMID 23794434.

Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients